Last updated: 2026-09-16 09:45:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
ClearPoint Neuro, Inc. (CLPT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $13,39, with a market capitalisation of $410,59M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8,27 to $30,10. This page covers its latest market performance, valuation, price trends and company information.
$410,59M | |
$13,13 | |
$31,29 | |
$2,86 | |
$13,15 | |
502,00 | |
742,87K | |
-- | |
$30,10 | |
$8,27 | |
-- | |
-- |
ClearPoint Neuro, Inc. (CLPT) is trading at $13,39 in pre-market trading as of 2026-09-16 09:17:00, up 1,86% ($0,24) from the previous close of $13,15
Pre-market trading shows how investors are pricing CLPT before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, ClearPoint Neuro, Inc. (CLPT) moved from $13,96 to $13,39, representing a decline of 4,05% ($0,57).
The stock traded between $12,99 and $14,22 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 590,21 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 23,5%
CLPT is currently trading at $13,39, placing it 23,5% of the way from its 52-week low of $8,27 to its 52-week high of $30,10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 172 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ClearPoint Neuro, Inc. (CLPT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.